Journal article · 2019

Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs

Olga Latinovic, Lauren M. Neal, Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, Robert Redfield

AIDS Research and Human Retroviruses, 35(8), 718–728 · Published 17 May 2019 · DOI 10.1089/aid.2018.0305

View at the publisherCite this paper

In brief

“Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs” is a 2019 journal article by Olga Latinovic and 8 co-authors, published in AIDS Research and Human Retroviruses. OpenAlex counts 12 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
12
Most cited in
2020 (4)
Field-weighted impact
0.82
References
54
Authors
9

Abstract

Significant progress has been made in the diagnostics and treatment of AIDS since the discovery of the human immunodeficiency virus type 1 (HIV-1) in 1983. The remarkable effectiveness of combined antiretroviral therapy (cART) is evidenced by mortality reduction, control of peripheral blood viral load, and in a nearly normal quality of HIV patients' lives. Remaining… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Latinovic, O., Neal, L. M., Tagaya, Y., Heredia, A., Medina-Moreno, S., Zapata, J. C., Reitz, M. S., Bryant, J., & Redfield, R. (2019). Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. AIDS Research and Human Retroviruses, 35(8), 718–728. https://doi.org/10.1089/aid.2018.0305

MLA 9

Latinovic, Olga, et al. “Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs.” AIDS Research and Human Retroviruses, vol. 35, no. 8, 2019, pp. 718–728. https://doi.org/10.1089/aid.2018.0305.

Chicago

Latinovic, Olga, Lauren M. Neal, Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, and Robert Redfield. 2019. “Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs.” AIDS Research and Human Retroviruses 35 (8): 718–728. https://doi.org/10.1089/aid.2018.0305.

Harvard

Latinovic, O. et al. (2019) ‘Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs’, AIDS Research and Human Retroviruses, 35(8), pp. 718–728. doi:10.1089/aid.2018.0305.

IEEE

O. Latinovic et al., “Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs,” AIDS Research and Human Retroviruses, vol. 35, no. 8, pp. 718–728, 2019, doi: 10.1089/aid.2018.0305.

BibTeX

@article{latinovic2019suppression,
  title     = {{Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs}},
  author    = {Latinovic, Olga and Neal, Lauren M. and Tagaya, Yutaka and Heredia, Alonso and Medina-Moreno, Sandra and Zapata, Juan Carlos and Reitz, Marvin S. and Bryant, Joseph and Redfield, Robert},
  journal   = {AIDS Research and Human Retroviruses},
  year      = {2019},
  volume    = {35},
  number    = {8},
  pages     = {718--728},
  doi       = {10.1089/aid.2018.0305},
  url       = {https://doi.org/10.1089/aid.2018.0305}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202044
202144
202211
202311
202411
202611

Its field-weighted citation impact is 0.82: it has been cited 0.82 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • HIV-1 infection
  • humanized NSG mice
  • CD34+ hematopoietic stem cells
  • highly active antiretroviral therapy
  • CCR5 antagonist
  • maraviroc
  • rapamycin
  • viral reservoir

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Latinovic, O., Neal, L. M., Tagaya, Y., Heredia, A., Medina-Moreno, S., Zapata, J. C., Reitz, M. S., Bryant, J., & Redfield, R. (2019). Suppression of Active HIV-1 Infection in CD34 + Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. AIDS Research and Human Retroviruses, 35(8), 718–728. https://doi.org/10.1089/aid.2018.0305

How many times has this paper been cited?

12 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Olga Latinovic, Lauren M. Neal, Yutaka Tagaya, Alonso Heredia, Sandra Medina-Moreno, Juan Carlos Zapata, Marvin S. Reitz, Joseph Bryant, Robert Redfield.

What is the DOI of this paper?

10.1089/aid.2018.0305, permanently at https://doi.org/10.1089/aid.2018.0305. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.